Rydex Health Care Fund Class Investor (RYHIX)

Fund Assets	19.53M
Expense Ratio	1.40%
Min. Investment	$2,500
Turnover	244.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 16, 2025

Previous Close	160.89
YTD Return	16.18%
1-Year Return	29.95%
5-Year Return	26.34%
52-Week Low	124.43
52-Week High	160.89
Beta (5Y)	0.80
Holdings	135
Inception Date	Apr 17, 1998

About RYHIX

Rydex Health Care Fund Investor Class is an open-end mutual fund focused on achieving capital appreciation by investing primarily in companies within the health care sector. The fund is managed by Guggenheim Investments and has a long-standing history, with an inception date of April 1998. Its investment strategy commits at least 80% of net assets to equity securities of health care companies, encompassing a broad range of sub-industries such as pharmaceuticals, biotechnology, medical devices, and health care providers. The fund may include holdings from both large, well-established firms and smaller, innovative companies, providing diversified exposure to the sector’s growth and innovation dynamics. With an annual distribution frequency for both capital gains and dividends, the fund is team-managed and aims to benefit from the demographic trends and ongoing advances that drive the health care industry. It charges a net expense ratio of 1.40% and is designed for investors seeking specialized exposure to the health care market as part of a broader diversified investment portfolio.

• Fund Family: Rydex Funds
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: RYHIX
• Share Class: Investor Class
• Index: S&P 500 TR

Performance

RYHIX had a total return of 29.95% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.76%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FIKCX	Fidelity	Fidelity Advisor Health Care Z	0.56%
FSPHX	Fidelity	Fidelity Select Health Care Portfolio	0.62%
FIJYX	Fidelity	Fidelity Advisor Biotechnology Z	0.58%
FSHCX	Fidelity	Fidelity Select Health Care Services Portfolio	0.67%
FBTAX	Fidelity	Fidelity Advisor Biotechnology A	0.96%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
RYHEX	Class A	1.65%
RYHAX	Class H	1.65%
RYHCX	Class C	2.40%

Top 10 Holdings

24.47% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	4.32%
Johnson & Johnson	JNJ	3.42%
AbbVie Inc.	ABBV	2.99%
UnitedHealth Group Incorporated	UNH	2.64%
Merck & Co., Inc.	MRK	2.42%
Thermo Fisher Scientific Inc.	TMO	1.91%
Amgen Inc.	AMGN	1.85%
Abbott Laboratories	ABT	1.68%
Gilead Sciences, Inc.	GILD	1.65%
Vertex Pharmaceuticals Incorporated	VRTX	1.59%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$2.99915	Dec 16, 2025
Dec 20, 2022	$1.88996	Dec 20, 2022
Dec 8, 2021	$4.23477	Dec 8, 2021
Dec 9, 2020	$10.14672	Dec 9, 2020
Dec 11, 2018	$1.51173	Dec 11, 2018
Dec 12, 2017	$7.88517	Dec 12, 2017

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error